NicOx SA Launches Commercial Operations In Germany

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOPHIA ANTIPOLIS, France, June 30, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today announced the launch of its German operations. Nicox is now promoting and selling Xailin(TM), a new range of tear lubricants for relief of dry eye symptoms (medical devices), and AdenoPlus®, an in vitro diagnostic medical device (IVDMD) to help the differential diagnosis of acute conjunctivitis, through its own sales force in Germany.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC